Judge Bounces Derivative Suit Against Cell Therapeutics
Months after tossing out a private class action against Cell Therapeutics Inc., a federal judge has dismissed a derivative lawsuit accusing the Seattle biopharmaceutical's directors of making false statements regarding the...To view the full article, register now.
Already a subscriber? Click here to view full article